Life sciences manufacturers continue to struggle with achieving the optimal and cost-effective market access strategy due to challenges in four key areas:

• Benchmarking distribution models and pharmacy network composition.
• Sizing and segmenting pharmacies and provider accounts based on demand for a competitive product group.
• Insight to the prevalence and terms and conditions of Payer, GPO, Health System, Distributor and Pharmacy contracts.
• Benchmarking Gross-to-Net line items against a market basket of analogous products.

Download now!